A pooled analysis of two randomised trials has shown that gemcitabine in combination with a platinumanalogue (cisplatin or oxaliplatin) is a potential front-line treatment option in advanced pancreatic adenocarcinoma.
Related Articles
Senza categoria
Newsround
Featured
Hereditary mutations in cancer: the use of panels and genetic counselling
Senza categoria
Leave a Reply